Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction.
van Dijk, Annemieke
Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction. [electronic resource] - Apoptosis : an international journal on programmed cell death Jun 2009 - 753-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-675X
10.1007/s10495-009-0350-x doi
Animals
Apoptosis--drug effects
Caspase 3--metabolism
Cell Membrane--drug effects
Cell Movement--drug effects
Disease Models, Animal
Enzyme Inhibitors--pharmacology
Group II Phospholipases A2--antagonists & inhibitors
Heart Function Tests
Immunohistochemistry
Macrophages--cytology
Myocardial Infarction--enzymology
Myocytes, Cardiac--cytology
Neutrophils--cytology
Rats
Rats, Wistar
Simvastatin--pharmacology
Solubility--drug effects
Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction. [electronic resource] - Apoptosis : an international journal on programmed cell death Jun 2009 - 753-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-675X
10.1007/s10495-009-0350-x doi
Animals
Apoptosis--drug effects
Caspase 3--metabolism
Cell Membrane--drug effects
Cell Movement--drug effects
Disease Models, Animal
Enzyme Inhibitors--pharmacology
Group II Phospholipases A2--antagonists & inhibitors
Heart Function Tests
Immunohistochemistry
Macrophages--cytology
Myocardial Infarction--enzymology
Myocytes, Cardiac--cytology
Neutrophils--cytology
Rats
Rats, Wistar
Simvastatin--pharmacology
Solubility--drug effects